What is the most recent earnings date for NEO stock?
NEOGENOMICS INC (NEO) last reported earnings on 2/17/2026.
NASDAQ:NEO • US64049M2098
Past quarterly earnings results for NEOGENOMICS INC (NEO), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | 0.06 | 0.04 | 53.54% | 50.00% | 190.17M | 189.93M | 0.13% | 10.56% |
| Q3 2025 | 0.03 | 0.02 | 40.97% | -40.00% | 187.797M | 185.61M | 1.18% | 11.90% |
| Q2 2025 | 0.03 | 0.02 | 31.60% | - | 181.33M | 184.52M | -1.73% | 10.23% |
| Q1 2025 | 0.00 | -0.01 | 100.00% | 100.00% | 168.035M | 172.67M | -2.68% | 7.55% |
| Q4 2024 | 0.04 | 0.03 | 35.03% | 33.33% | 172M | 174.91M | -1.66% | 10.57% |
| Q3 2024 | 0.05 | 0.01 | 298.27% | - | 167.824M | 168.68M | -0.51% | 10.44% |
| Q2 2024 | 0.03 | 0.00 | 871.51% | 160.00% | 164.502M | 163.47M | 0.63% | 11.97% |
| Q1 2024 | -0.02 | -0.05 | 59.66% | 77.78% | 156.24M | 151.39M | 3.20% | 13.86% |
| Q4 2023 | 0.03 | -0.03 | 219.19% | 150.00% | 155.552M | 154.06M | 0.97% | 12.15% |
| Q3 2023 | 0.00 | -0.08 | 100.00% | 100.00% | 151.954M | 143.06M | 6.22% | 17.98% |
| Q2 2023 | -0.05 | -0.11 | 56.40% | 68.75% | 146.917M | 138.8M | 5.85% | 17.44% |
| Q1 2023 | -0.09 | -0.15 | 41.11% | 55.00% | 137.22M | 127.66M | 7.49% | 17.08% |
| Q4 2022 | -0.06 | -0.17 | 63.95% | 57.14% | 138.7M | 131.27M | 5.66% | 10.34% |
| Q3 2022 | -0.14 | -0.21 | 32.66% | -75.00% | 128.8M | 122.75M | 4.93% | 6.18% |
| Q2 2022 | -0.16 | -0.23 | 29.71% | -1,500.00% | 125.1M | 124.56M | 0.43% | 2.79% |
| Q1 2022 | -0.20 | -0.24 | 15.83% | -400.00% | 117.2M | 117.85M | -0.55% | 1.47% |
| Q4 2021 | -0.14 | -0.15 | 4.71% | -200.00% | 125.7M | 127.04M | -1.05% | -0.24% |
| Q3 2021 | -0.08 | -0.09 | 7.45% | -233.33% | 121.3M | 126.31M | -3.97% | -3.27% |
| Q2 2021 | -0.01 | -0.06 | 84.39% | 75.00% | 121.7M | 119.16M | 2.13% | 39.89% |
| Q1 2021 | -0.04 | 0.01 | -463.01% | -100.00% | 115.5M | 113.53M | 1.74% | 8.96% |
| Q4 2020 | 0.14 | 0.06 | 120.97% | - | 126M | 125.51M | 0.39% | - |
| Q3 2020 | 0.06 | 0.04 | 56.33% | - | 125.4M | 127.49M | -1.64% | - |
| Q2 2020 | -0.04 | -0.10 | 61.83% | - | 87M | 87.418M | -0.48% | - |
| Q1 2020 | -0.02 | 0.02 | -199.01% | - | 106M | 105.63M | 0.35% | - |
Notes
NEOGENOMICS INC (NEO) last reported earnings on 2/17/2026.
NEOGENOMICS INC (NEO) beat EPS estimates and beat revenue estimates in the most recent quarter.
In the last 4 quarters, NEOGENOMICS INC (NEO) has beaten EPS estimates in 4 out of 4 releases.